News und Analysen
![Humana’s Annual Report on Employee Well-Being Illustrates the Company’s Culture and Highlights Resiliency](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Humana’s Annual Report on Employee Well-Being Illustrates the Company’s Culture and Highlights Resiliency
Humana Inc. (NYSE: HUM) has released its latest annual report on employee well-being, which continues to show that passion for whole-person well-being, both inside and outside the workplace, can
![Premier Inc. Survey: Clinically Integrated Networks in Alternative Payment Models Expanded Value-Based Care Capabilities to Manage COVID-19 Surge](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Premier Inc. Survey: Clinically Integrated Networks in Alternative Payment Models Expanded Value-Based Care Capabilities to Manage COVID-19 Surge
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released survey results finding that participants in alternative payment models (APMs) have drawn heavily on their
![Save the Date: Pfizer Announces New Date of September 14, 2020 for Rescheduled Investor Day](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Save the Date: Pfizer Announces New Date of September 14, 2020 for Rescheduled Investor Day
Pfizer Inc. (NYSE: PFE) announced today that it will be holding its rescheduled Investor Day on Monday, September 14, 2020 at 9:00 a.m. EDT. Pfizer postponed its Investor Day, originally scheduled
![China NMPA Approves Optune® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
China NMPA Approves Optune® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
Novocure (NASDAQ: NVCR), a global oncology company with a proprietary platform therapy called Tumor Treating Fields, and Zai Lab Limited (NASDAQ: ZLAB), an innovative commercial stage
![Xencor to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Xencor to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced that Bassil
![Simulations Plus to Present at 15th Annual Needham Virtual Technology & Media Conference](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Simulations Plus to Present at 15th Annual Needham Virtual Technology & Media Conference
Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief
![ICON plc to Present at UBS Virtual Global Healthcare Conference](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
ICON plc to Present at UBS Virtual Global Healthcare Conference
ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Mr
![New Data from 18 Approved and Investigational Pfizer Medicines to be Showcased at ASCO20 Virtual Scientific Program](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
New Data from 18 Approved and Investigational Pfizer Medicines to be Showcased at ASCO20 Virtual Scientific Program
Pfizer Inc. (NYSE: PFE) today announced that new data from clinical trials of 18 approved and investigational medicines will be presented virtually at the ASCO20 Virtual Scientific Program, from
![Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Charles Triano, Senior Vice President, Investor Relations, at the RBC Capital Markets
![Sangamo Therapeutics Announces Participation at the Bank of America 2020 Health Care Conference](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Sangamo Therapeutics Announces Participation at the Bank of America 2020 Health Care Conference
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the Bank of America 2020 Health Care Conference on Thursday, May 14 at 4:20
![Agilent Awards Trilogy Sciences with a Golden Ticket at LabCentral](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Agilent Awards Trilogy Sciences with a Golden Ticket at LabCentral
Agilent Technologies Inc. (NYSE: A) announces that biotech startup Trilogy Sciences has been awarded an Agilent Golden Ticket at LabCentral, a leading biotech innovation hub based in Cambridge
![DexCom Prices Offering of Upsized $1.05 Billion of 0.25% Convertible Senior Notes](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
DexCom Prices Offering of Upsized $1.05 Billion of 0.25% Convertible Senior Notes
DexCom, Inc. (Nasdaq: DXCM) (“DexCom”) announced today the pricing of its offering of $1.05 billion aggregate principal amount of 0.25% Convertible Senior Notes due 2025 (the “notes”) in a private
![CymaBay: April-Empfehlung mit +196% Kursgewinn!](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
CymaBay: April-Empfehlung mit +196% Kursgewinn!
Die Party im No Brainer Club kennt derzeit wieder keine Grenzen. Mit CymaBay Therapeutics (WKN: A116DD) ist der nächste Vervielfacher eingetütet – in kaum mehr als einem Monat!
Die NBC-Experten
![American Renal Associates Holdings, Inc. Announces First Quarter 2020 Results](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
American Renal Associates Holdings, Inc. Announces First Quarter 2020 Results
American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced financial and
![Sangamo Therapeutics Reports Business Highlights and First Quarter 2020 Financial Results](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Sangamo Therapeutics Reports Business Highlights and First Quarter 2020 Financial Results
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported first quarter 2020 financial results and recent business highlights.
“I’m proud of how the Sangamo team has
![Humana Specialty Pharmacy Wins National Award for Third Consecutive Year](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Humana Specialty Pharmacy Wins National Award for Third Consecutive Year
Humana Specialty Pharmacy has received the Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the third year in a row. The award, presented by Zitter Health Insights, a division
![Molina Healthcare of Ohio Commits $1.5 Million to Advance the Health of Ohioans Through its 2020 Community Innovation Fund](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Molina Healthcare of Ohio Commits $1.5 Million to Advance the Health of Ohioans Through its 2020 Community Innovation Fund
Molina Healthcare of Ohio (“Molina”) is dedicated to building healthier communities and is committing over $1.5 million to support innovative programs across Ohio.
The Molina Community Innovation
![Humana Announces Additional Bold Goal Communities in Cincinnati and Detroit](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Humana Announces Additional Bold Goal Communities in Cincinnati and Detroit
Humana Inc. (NYSE: HUM) announced today that Cincinnati, Ohio and Detroit, Michigan are the latest additions to its Bold Goal communities. The Bold Goal is Humana’s population health strategy to
![LivaNova to Present at the UBS Virtual Global Healthcare Conference](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
LivaNova to Present at the UBS Virtual Global Healthcare Conference
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Damien McDonald, Chief Executive Officer, will present at the UBS Virtual Global Healthcare Conference on
![Navidea Biopharmaceuticals Regains Commercialization and Distributions Rights in Europe for LYMPHOSEEK®](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Navidea Biopharmaceuticals Regains Commercialization and Distributions Rights in Europe for LYMPHOSEEK®
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, is pleased to
![DexCom Announces Proposed Offering of $850.0 Million of Convertible Senior Notes](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
DexCom Announces Proposed Offering of $850.0 Million of Convertible Senior Notes
DexCom, Inc. (Nasdaq: DXCM) (“DexCom”) announced today that it intends to offer, subject to market conditions and other factors, $850.0 million aggregate principal amount of Convertible Senior
![NanoRepro: Nicht mehr als eine Push-News!](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
NanoRepro: Nicht mehr als eine Push-News!
NanoRepro (WKN: 657710) meldet die Auslieferung seines Covid-19-Schnelltests. Die Zocker-Aktie springt mal wieder in die Höhe. Doch auch diesmal gilt: Die Chance sollte zum Ausstieg genutzt werden!
![NanoString to Present at the Bank of America Health Care Conference](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
NanoString to Present at the Bank of America Health Care Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present
![Quidel Receives Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Quidel Receives Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has
![DexCom, Inc. Announces Change of Location of Annual Meeting of Stockholders to Be Held May 21, 2020](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
DexCom, Inc. Announces Change of Location of Annual Meeting of Stockholders to Be Held May 21, 2020
DexCom, Inc. (NASDAQ:DXCM) today announced that, due to the public health impact of the COVID-19 pandemic, the location of the 2020 Annual Meeting of Stockholders of DexCom, Inc. (the “Company”)